Skip to main content
Fig. 4 | BMC Genomics

Fig. 4

From: Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer

Fig. 4

Kaplan-Meier plots for Recurrence Free Survival (Discovery cohort). Kaplan-Meier plots were used to estimate RFS in Case–control approach (a) and Case-only approach (b). Log rank test was performed to assess differences in survival between the two risk groups. Patients belonging to the high-risk group had shorter RFS in both (a) and (b)

Back to article page